news

IOC Executive Board approves Olympic medal reallocations for Vancouver 2010 and Sochi 2014

19 September 2025 - The International Olympic Committee (IOC) Executive Board (EB) today took the decision to reallocate Olympic medals, diplomas and medallist…

9 months ago

IOC Executive Board approves 13 athletes changes of sporting nationality for the Milano Cortina 2026 Olympic Winter Games

19 September 2025 - Today, during the second day of its meeting in Milan, the International Olympic Committee (IOC) Executive Board (EB)…

9 months ago

IOC reaffirms: Sport must unite the world in peaceful competition

19 September 2025 - In a world shaken by conflict and division, the International Olympic Committee (IOC) Executive Board (EB) stands firm in…

9 months ago

Bravo Flowdex: How This Innovative Platform is Redefining AI Trading Read Bravo Flowdex Spain Report!

New York City, NY, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Introduction – What is Bravo Flowdex Bravo Flowdex is a…

9 months ago

Net Rowdex: Why Net Rowdex 2025 Emerges as a Next-Gen AI Trading Platform for Investors Read France Report!

New York City, NY, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Introduction to Net Rowdex Net Rowdex emerges in 2025 as…

9 months ago

Immediate Edge: Exploring the AI Technology Behind Immediate Edge Trading Platform Germany Insights!

New York City, NY, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Introduction to Immediate Edge Immediate Edge is a cutting-edge AI-powered…

9 months ago

Sasken Partners with VicOne to Deliver End-to-End Automotive Cybersecurity Solutions

BENGALURU, India, Sept. 20, 2025 /PRNewswire/ -- Sasken Technologies Limited, a leader in product engineering and digital transformation, today announced…

9 months ago

C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting

September 20, 2025 11:00 ET  | Source: C4 Therapeutics, Inc. Cemsidomide in Combination With Dexamethasone Achieved a 50% Overall Response…

9 months ago

Multiple Myeloma Research Foundation (MMRF) Announces New Data from Flagship Research Initiatives at the 22nd International Myeloma Society Annual Meeting

NORWALK, Conn., Sept. 20, 2025 (GLOBE NEWSWIRE) -- Today, the Multiple Myeloma Research Foundation® (MMRF) announced that data generated from…

9 months ago

MBX Biosciences to Provide Topline Results from its Phase 2 Trial of Potential Once-Weekly Canvuparatide for Hypoparathyroidism (HP) on Monday, September 22

September 19, 2025 16:18 ET  | Source: MBX Biosciences, Inc. CARMEL, Ind., Sept. 19, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences,…

9 months ago